Talk Sense | |
11823 Old Glenn Hwy, 108, Eagle River, AK 99577-7734 | |
(907) 694-8255 | |
Not Available |
Full Name | Talk Sense |
---|---|
Type | Facility |
Speciality | Speech-language Pathologist |
Location | 11823 Old Glenn Hwy, Eagle River, Alaska |
Accepts Medicare Assignments | Does not participate in Medicare Program. The facility may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1821418948 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
235Z00000X | Speech-language Pathologist | 431 (Alaska) | Primary |
261QR0400X | Clinic/center - Rehabilitation | 2469 (Alaska) | Secondary |
Mailing Address | Practice Location Address |
---|---|
Talk Sense Po Box 241889, Anchorage, AK 99524-1889 Ph: (907) 563-1777 | Talk Sense 11823 Old Glenn Hwy, 108, Eagle River, AK 99577-7734 Ph: (907) 694-8255 |
News Archive
A little bit of learned fear is a good thing, keeping us from making risky, stupid decisions or falling over and over again into the same trap. But new research from neuroscientists and molecular biologists at USC shows that a missing brain protein may be the culprit in cases of severe over-worry, where the fear perseveres even when there's nothing of which to be afraid.
Urovalve, a medical device company focused on creating superior products for urinary flow and control, announced today that the U.S. Food and Drug Administration (FDA) has granted Investigational Device Exemption (IDE) approval for the Company's Surinate® Bladder Management System, allowing Urovalve to conduct a clinical study for the Company's lead device in the United States.
Researchers at the Stanford University School of Medicine have identified the cancer stem cells that propagate tumors in colon and rectal cancer, a discovery that could lead to improved treatment of this deadly cancer.
Takeda Pharmaceutical Company Limited ("Takeda") and Takeda Global Research & Development Center, Inc., a wholly owned United States (U.S.) subsidiary, today jointly announced that the latter has received notification that the U.S. Food and Drug Administration (FDA) has agreed to the study design for a cardiovascular (CV) outcomes trial titled EXAMINE (EXamination of CArdiovascular OutcoMes: AlogliptIN vs. Standard of CarE in Patients with Type 2 Diabetes Mellitus and Acute Coronary Syndrome) for alogliptin, a selective dipeptidyl peptidase IV inhibitor under investigation for the treatment of type 2 diabetes as an adjunct to diet and exercise.
› Verified 7 days ago
It's More Than Speech Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 12812 Old Glenn Hwy Ste A3, Eagle River, AK 99577 Phone: 907-244-0953 Fax: 800-645-2157 | |
Talented People Llc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 16643 Yellowstone Cir, Eagle River, AK 99577 Phone: 907-276-5055 Fax: 907-696-4119 | |
Audrey Means, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 16635 Centerfield Dr Ste 103, Eagle River, AK 99577 Phone: 907-694-6002 | |
Mrs. Tonya Lynn Buczkowski, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 9001 Andy Cir, Eagle River, AK 99577 Phone: 907-694-4806 | |
Specialized Speech Services, Llc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 10928 Eagle River Rd Ste 104, Eagle River, AK 99577 Phone: 907-854-6935 Fax: 855-262-3448 | |
Mrs. Heather Lynn Jasser, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 18711 Danny Dr, Eagle River, AK 99577 Phone: 907-244-2819 | |
Brooke Alydia Plaster, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 11723 Old Glenn Hwy Ste 206, Eagle River, AK 99577 Phone: 907-301-4588 |